Arcus Prices 14.3 Million-Share Offering at $17.50 Each
Arcus Biosciences expects to raise $250 million in gross proceeds from the follow-on share sale, before underwriting discounts and expenses. Shares fell premarket.
By Rob CurranShares of Arcus Biosciences fell premarket after the biotech company priced a 14.3 million-share follow-on offering at $17.50 apiece.The Hayward, Calif., developer of cancer therapies said it expects to raise $250 million in gross proceeds from the share sale, before deducting underwri…